Terms: = Liver cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Prognosis
74 results:
1. COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.
Liu J; Han D; Xuan J; Xie J; Wang W; Zhou Q; Chen K
Aging (Albany NY); 2024 Mar; 16(6):5264-5287. PubMed ID: 38466642
[TBL] [Abstract] [Full Text] [Related]
2. ZBTB7B is a permissive regulator of hepatocellular carcinoma initiation by repressing c-jun expression and function.
Zhu Y; Wang Q; Xie X; Ma C; Qiao Y; Zhang Y; Wu Y; Gao Y; Jiang J; Liu X; Chen J; Li C; Ge G
Cell Death Dis; 2024 Jan; 15(1):55. PubMed ID: 38225233
[TBL] [Abstract] [Full Text] [Related]
3. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway.
Lou YX; Gu J; Zhu L; Sun SQ; Hao XL; Chen JP; Han F; Wang DD; Jiang X; Liu JY
Lab Invest; 2023 Dec; 103(12):100260. PubMed ID: 37839635
[TBL] [Abstract] [Full Text] [Related]
4. Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-jun/ACSL3 in hepatocellular carcinoma.
Lu Y; Liang H; Li X; Chen H; Yang C
Aging (Albany NY); 2023 May; 15(11):4699-4713. PubMed ID: 37294538
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of JNK/c-jun-ATF2 Overcomes Cisplatin Resistance in liver cancer through down-Regulating Galectin-1.
Yang F; Li M; Xu D; Jiang Z; Jiang H; Xiao Y; Mei C; Yang M; Chen C; Zhou B; He B; Shan H; Pang P; Li D
Int J Biol Sci; 2023; 19(8):2366-2381. PubMed ID: 37215991
[TBL] [Abstract] [Full Text] [Related]
6. Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC.
Shi J; Li G; Liu L; Yuan X; Wang Y; Gong M; Li C; Ge X; Lu S
Front Immunol; 2023; 14():1166052. PubMed ID: 37077914
[TBL] [Abstract] [Full Text] [Related]
7. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates liver cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
[TBL] [Abstract] [Full Text] [Related]
8. Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/jun/HK2 axis regulated glycolysis.
Mi Y; Li Q; Liu B; Wang D; Liu Z; Wang T; Wang Y; Zang Y; Zhou Y; Wen Y; Ding Y
Gastric Cancer; 2023 Jan; 26(1):69-81. PubMed ID: 36114400
[TBL] [Abstract] [Full Text] [Related]
9. Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/jun-mediated signaling pathway.
Miao H; Geng Y; Li Y; Tang S; Feng F; Li W; Li Y; Liu L; Zhang R; Qiu S; Wu Y; Wang Z; Wang Z; Shao Z; Liu K; Zou L; Yang M; Zhao Y; Chen C; Li Z; Zhang D; Peng P; Qiang X; Wu F; He Y; Chen L; Xiang D; Jiang X; Li M; Liu Y; Liu Y
Cell Oncol (Dordr); 2022 Aug; 45(4):689-708. PubMed ID: 35870050
[TBL] [Abstract] [Full Text] [Related]
10. Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner.
Wang J; Liu X; Chu H; Chen J
PeerJ; 2022; 10():e13535. PubMed ID: 35694386
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of multiple databases identifies crucial genes correlated with prognosis of hepatocellular carcinoma.
Lin Z; Huang X; Ji X; Tian N; Gan Y; Ke L
Sci Rep; 2022 May; 12(1):9002. PubMed ID: 35637248
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathological festures and outcome of combined hepatocellular-cholangiocarcinoma].
Ye DL; Zong JW; Luo JX; Cui WZ; Wang W
Zhonghua Yi Xue Za Zhi; 2022 May; 102(18):1369-1373. PubMed ID: 35545581
[No Abstract] [Full Text] [Related]
13. ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-jun/MYH9/USP7/c-Myc axis.
Hou R; Li Y; Luo X; Zhang W; Yang H; Zhang Y; Liu J; Liu S; Han S; Liu C; Huang Y; Liu Z; Li A; Fang W
Int J Biol Sci; 2022; 18(6):2553-2567. PubMed ID: 35414777
[TBL] [Abstract] [Full Text] [Related]
14. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
[TBL] [Abstract] [Full Text] [Related]
15. BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-jun pathways.
Jiao CY; Feng QC; Li CX; Wang D; Han S; Zhang YD; Jiang WJ; Chang J; Wang X; Li XC
Cell Death Dis; 2021 Jan; 12(1):63. PubMed ID: 33431813
[TBL] [Abstract] [Full Text] [Related]
16. Emerging roles of DYRK2 in cancer.
Tandon V; de la Vega L; Banerjee S
J Biol Chem; 2021; 296():100233. PubMed ID: 33376136
[TBL] [Abstract] [Full Text] [Related]
17. ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β‑catenin signaling pathway.
Chen QF; Shi F; Huang T; Huang C; Shen L; Wu P; Li W
Oncol Rep; 2020 Oct; 44(4):1425-1440. PubMed ID: 32945491
[TBL] [Abstract] [Full Text] [Related]
18. circNFATC3 sponges miR-548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progression.
Jia C; Yao Z; Lin Z; Zhao L; Cai X; Chen S; Deng M; Zhang Q
J Cell Physiol; 2021 Feb; 236(2):1252-1269. PubMed ID: 32667692
[TBL] [Abstract] [Full Text] [Related]
19. Diospyros kaki leaves inhibit HGF/Met signaling-mediated EMT and stemness features in hepatocellular carcinoma.
Ko H; Huh G; Jung SH; Kwon H; Jeon Y; Park YN; Kim YJ
Food Chem Toxicol; 2020 Aug; 142():111475. PubMed ID: 32522589
[TBL] [Abstract] [Full Text] [Related]
20. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
[TBL] [Abstract] [Full Text] [Related]
[Next]